Genus plc (FRA:GBE)

Market Cap	2.40B +65.8%
Revenue (ttm)	784.89M +0.6%
Net Income	22.52M +144.3%
EPS	0.34 +142.9%
Shares Out	n/a
PE Ratio	106.70
Forward PE	33.10
Dividend	0.37 (1.04%)
Ex-Dividend Date	Nov 6, 2025

Volume	n/a
Average Volume	48
Open	35.40
Previous Close	36.40
Day's Range	35.40 - 35.40
52-Week Range	18.10 - 36.40
Beta	n/a
RSI	57.93
Earnings Date	Feb 26, 2026

About Genus

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1994
• Employees: 3,190
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GBE

Financial Performance

In fiscal year 2025, Genus's revenue was 672.80 million, an increase of 0.60% compared to the previous year's 668.80 million. Earnings were 19.30 million, an increase of 144.30%.

Financial numbers in GBP